Abstract

BackgroundFatty liver disease (FLD) arises from the accumulation of fat in the liver and may cause liver inflammation, which, if not well controlled, may develop into liver fibrosis, cirrhosis, or even hepatocellular carcinoma.ObjectiveWe describe the construction of machine-learning models for current-visit prediction (CVP), which can help physicians obtain more information for accurate diagnosis, and next-visit prediction (NVP), which can help physicians provide potential high-risk patients with advice to effectively prevent FLD.MethodsThe large-scale and high-dimensional dataset used in this study comes from Taipei MJ Health Research Foundation in Taiwan. We used one-pass ranking and sequential forward selection (SFS) for feature selection in FLD prediction. For CVP, we explored multiple models, including k-nearest-neighbor classifier (KNNC), Adaboost, support vector machine (SVM), logistic regression (LR), random forest (RF), Gaussian naïve Bayes (GNB), decision trees C4.5 (C4.5), and classification and regression trees (CART). For NVP, we used long short-term memory (LSTM) and several of its variants as sequence classifiers that use various input sets for prediction. Model performance was evaluated based on two criteria: the accuracy of the test set and the intersection over union/coverage between the features selected by one-pass ranking/SFS and by domain experts. The accuracy, precision, recall, F-measure, and area under the receiver operating characteristic curve were calculated for both CVP and NVP for males and females, respectively.ResultsAfter data cleaning, the dataset included 34,856 and 31,394 unique visits respectively for males and females for the period 2009-2016. The test accuracy of CVP using KNNC, Adaboost, SVM, LR, RF, GNB, C4.5, and CART was respectively 84.28%, 83.84%, 82.22%, 82.21%, 76.03%, 75.78%, and 75.53%. The test accuracy of NVP using LSTM, bidirectional LSTM (biLSTM), Stack-LSTM, Stack-biLSTM, and Attention-LSTM was respectively 76.54%, 76.66%, 77.23%, 76.84%, and 77.31% for fixed-interval features, and was 79.29%, 79.12%, 79.32%, 79.29%, and 78.36%, respectively, for variable-interval features.ConclusionsThis study explored a large-scale FLD dataset with high dimensionality. We developed FLD prediction models for CVP and NVP. We also implemented efficient feature selection schemes for current- and next-visit prediction to compare the automatically selected features with expert-selected features. In particular, NVP emerged as more valuable from the viewpoint of preventive medicine. For NVP, we propose use of feature set 2 (with variable intervals), which is more compact and flexible. We have also tested several variants of LSTM in combination with two feature sets to identify the best match for male and female FLD prediction. More specifically, the best model for males was Stack-LSTM using feature set 2 (with 79.32% accuracy), whereas the best model for females was LSTM using feature set 1 (with 81.90% accuracy).

Highlights

  • BackgroundPrior research on the use of machine learning for early disease prediction has focused on diabetes, fatty liver disease (FLD), hypotension, and other metabolic syndromes [1]

  • We developed Fatty liver disease (FLD) prediction models for current-visit prediction (CVP) and next-visit prediction (NVP)

  • This study focused on the prediction of FLD, which is widespread in Taiwan, and could lead to liver cirrhosis, fibrosis, and liver cell death

Read more

Summary

Introduction

Prior research on the use of machine learning for early disease prediction has focused on diabetes, fatty liver disease (FLD), hypotension, and other metabolic syndromes [1]. This study focused on the prediction of FLD, which is widespread in Taiwan, and could lead to liver cirrhosis, fibrosis, and liver cell death. FLD increases the prevalence of diabetes, metabolic syndrome, and obesity, creating enormous medical and economic burdens for society. This situation raises an urgent need for early and precise prediction, followed by personalized treatment and lifestyle management. FLD has been classified into two types according to its cause: alcohol-related fatty liver disease (AFLD) and nonalcoholic fatty liver disease (NAFLD). Fatty liver disease (FLD) arises from the accumulation of fat in the liver and may cause liver inflammation, which, if not well controlled, may develop into liver fibrosis, cirrhosis, or even hepatocellular carcinoma

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call